These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 2062847)
1. CD4 peptide-protein conjugates, but not recombinant human CD4, bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients. Ghetie V; Slaughter C; Wheeler HT; Uhr JW; Vitetta ES Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5690-3. PubMed ID: 2062847 [TBL] [Abstract][Full Text] [Related]
2. Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity. McKeating J; Balfe P; Clapham P; Weiss RA J Virol; 1991 Sep; 65(9):4777-85. PubMed ID: 1870202 [TBL] [Abstract][Full Text] [Related]
3. A CD4-derived peptide carrier blocks acute HIV-1 infection in vitro and binds to gp120 in the presence of Walter-Reed stage 1-6 HIV+ sera. Ghetie V; Wheeler T; Scott D; Uhr JW; Vitetta ES AIDS Res Hum Retroviruses; 1992 Nov; 8(11):1945-8. PubMed ID: 1489581 [TBL] [Abstract][Full Text] [Related]
4. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. Batinić D; Robey FA J Biol Chem; 1992 Apr; 267(10):6664-71. PubMed ID: 1551875 [TBL] [Abstract][Full Text] [Related]
5. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis. Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059 [TBL] [Abstract][Full Text] [Related]
6. A human recombinant Fab identifies a human immunodeficiency virus type 1-induced conformational change in cell surface-expressed CD4. Bachelder RE; Bilancieri J; Lin W; Letvin NL J Virol; 1995 Sep; 69(9):5734-42. PubMed ID: 7637018 [TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4. Werner A; Levy JA J Virol; 1993 May; 67(5):2566-74. PubMed ID: 8474162 [TBL] [Abstract][Full Text] [Related]
8. Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120. Turner S; Tizard R; DeMarinis J; Pepinsky RB; Zullo J; Schooley R; Fisher R Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1335-9. PubMed ID: 1741386 [TBL] [Abstract][Full Text] [Related]
9. Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4. Harrop HA; Rider CC Glycobiology; 1998 Feb; 8(2):131-7. PubMed ID: 9451022 [TBL] [Abstract][Full Text] [Related]
10. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds. Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion. Berger EA; Lifson JD; Eiden LE Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8082-6. PubMed ID: 1896455 [TBL] [Abstract][Full Text] [Related]
12. Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies. Kaiser PK; Offermann JT; Lipton SA Neurology; 1990 Nov; 40(11):1757-61. PubMed ID: 2234433 [TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex. Fouts TR; Tuskan R; Godfrey K; Reitz M; Hone D; Lewis GK; DeVico AL J Virol; 2000 Dec; 74(24):11427-36. PubMed ID: 11090138 [TBL] [Abstract][Full Text] [Related]
14. The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4 molecule. Meiyu G; Fuchuan L; Xianliang X; Jing L; Zuowei Y; Huashi G Antiviral Res; 2003 Jul; 59(2):127-35. PubMed ID: 12895696 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-1 rgp120 binding to CD4+ T cells by monoclonal antibodies directed against the gp120 C1 or C4 region. Kröpelin M; Süsal C; Daniel V; Opelz G Immunol Lett; 1998 Aug; 63(1):19-25. PubMed ID: 9719434 [TBL] [Abstract][Full Text] [Related]
16. Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Kang CY; Nara P; Chamat S; Caralli V; Ryskamp T; Haigwood N; Newman R; Köhler H Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6171-5. PubMed ID: 2068099 [TBL] [Abstract][Full Text] [Related]
17. Jacalin, a lectin with anti-HIV-1 properties, and HIV-1 gp120 envelope protein interact with distinct regions of the CD4 molecule. Corbeau P; Haran M; Binz H; Devaux C Mol Immunol; 1994 Jun; 31(8):569-75. PubMed ID: 8196669 [TBL] [Abstract][Full Text] [Related]
18. HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor. Bashir T; Patgaonkar M; Kumar SC; Pasi A; Reddy KV PLoS One; 2015; 10(4):e0124839. PubMed ID: 25915507 [TBL] [Abstract][Full Text] [Related]
19. Red blood cells bearing CD4 bind to gp120 covered plates and aggregate with cells expressing gp120. Arvinte T; Schulz B; Madoulet C; Nicolau C J Acquir Immune Defic Syndr (1988); 1990; 3(11):1041-5. PubMed ID: 1698964 [TBL] [Abstract][Full Text] [Related]
20. Internal-image anti-idiotype HIV-1gp120 antibody in human immunodeficiency virus 1 (HIV-1)-seropositive individuals with thrombocytopenia. Karpatkin S; Nardi MA; Kouri YH Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1487-91. PubMed ID: 1741404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]